Spots Global Cancer Trial Database for Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Allogenic Stem Cell Transplantation (SCT) With Non-myeloablative Conditioning in Patients With Relapse Non-Hodgkin's Lymphoma (NHL)
Official Title: Allogeneic Transplantation of Haematopoietic Stem Cells Following Non-myeloablative Conditioning With Melphalan, Fludarabine, Thiotepa, Rituximab and Ibritumomab Tiuxetan (Zevalin) in Patients With Aggressive Non-Hodgkin's B-cell Lymphoma
Study ID: NCT00644371
Conditions
Interventions
Study Description
Brief Summary: To evaluate the use of ibritumomab tiuxetan (Zevalin) as part of the non myeloablative conditioning with melphalan, fludarabine and thiotepa in patients submitted to allogeneic transplantation of haematopoietic stem cells from family donor's peripheral blood.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
H. Santa Creu i Sant Pau., Barcelona, Barcelona., Spain
Clinica Universitaria de Navarra, Pamplona, Navarra, Spain
H.U. 12 de Octubre, Madrid, , Spain
H.U. Gregorio Marañón, Madrid, , Spain
H.U. La Princesa, Madrid, , Spain
H.U. Ramón y Cajal., Madrid, , Spain
H. Morales Meseguer., Murcia, , Spain
H. Virgen de la Arrixaca, Murcia, , Spain
H. Central de Asturias, Oviedo, , Spain
H. Clinico de Salamanca, Salamanca, , Spain
H. U. Marqués de Valdecilla., Santander, , Spain
H. Clínico Valencia, Valencia, , Spain
H. La Fe, Valencia, , Spain
H.U. Miguel Servet, Zaragoza., , Spain
Contact Details
Name: Dolores Caballero, MD
Affiliation: Hospital Clínico Universitario de Salamanca
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
